DNAGinkgo+PlatformTWSTTwist+SynthesisABSIAbsci+AIDesignCRSPCRISPR Therapeutics+EditBEAMBeam+BaseEditNTLAIntellia+InVivoCRBUCaribou+CellTherapyRXRXRecursion+AIILMNIllumina+SeqEDITEditas+GeneFUND.YTD2025$17.3B.Raised
Terminal/Companies/Caribou Biosciences
publicFounded 2011

Caribou Biosciences

HQ: Berkeley, CA, USACEO: Rachel HaurwitzHeadcount: 200+cariboubio.com
Funding Summary
Total Funding
$400M+
Latest Valuation
~$300M (public market cap)
About

Co-founded by Jennifer Doudna, develops off-the-shelf CRISPR-edited cell therapies using proprietary chRDNA hybrid system for hematological cancers.

platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →